• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

InSite Vision Inc

+ Add to Watchlist


0.1700 USD 0.0250 12.82%

As of 20:10:04 ET on 12/26/2014.

Snapshot for InSite Vision Inc (INSV)

Open: 0.1900 Day's Range: 0.1680 - 0.1900 Volume: 1,677,843
Previous Close: 0.1950 52wk Range: 0.1000 - 0.3600 1-Yr Rtn: -42.37%

Stock Chart for INSV

No chart data available.
  • INSV:US 0.1700
  • 1D
  • 1M
  • 1Y
Interactive INSV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSV

Current P/E Ratio (ttm) 56.6667
Estimated P/E(12/2014) 0.8500
Relative P/E vs. SPX 3.0634
Earnings Per Share (USD) (ttm) 0.0030
Est. EPS (USD) (12/2014) 0.2000
Est. PEG Ratio -
Market Cap (M USD) 22.43
Shares Outstanding (M) 131.95
30 Day Average Volume 185,600
Price/Book (mrq) -
Price/Sale (ttm) 2.5119
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSV

InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.

Timothy M RuaneChief Executive OfficerKamran HosseiniChief Medical Officer
Louis C DrapeauVP/CFOLyle M BowmanVP:Development/Secretary
More Company Profile & Key Executives for INSV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • INSV News

  • Industry News

No stories found
No stories found
Sponsored Links
sec ||= nil